معرفی
Prof. Dr. Frieder Schwenk is a Professor at Westfälische Hochschule since 2003, specializing in Biomedical Research. He serves as Subject Advisor for the Master's program "Molecular Biology," Biological Safety Officer (BBS), and Timetable Officer in the Department of Engineering and Natural Sciences (FB 8) at the Westphalian Institute of Health.
His educational background includes:
- Biology Diploma (1987-1991) at Universität zu Köln
- Diploma thesis (1992) on MHC Class II-associated Invariant Chain at Universität Bonn
- PhD (1993-1997) on conditional mutagenesis technologies at Universität Köln
Prof. Schwenk's research focuses on Molecular Biology, particularly stem cell differentiation, gene targeting, conditional mutagenesis, genome editing, and RNA interference. His work centers on developing genetic model organisms for biomedical research, with applications in pharmaceutical development including pluripotent stem cell differentiation as models for natural regeneration processes and technologies for targeted gene modification. His teaching encompasses Molecular Biology, Molecular Physiology, Pathophysiology, and Drug Development across Bachelor's and Master's programs.
His extensive publication record demonstrates consistent contributions to genetic engineering techniques, particularly in mouse models. His work spans molecular biology, genetics, epigenetics, neuroscience, and immunology, with a strong emphasis on developing and refining gene targeting and editing technologies for biomedical applications. The evolution of his research shows progression from fundamental molecular techniques to sophisticated applications in disease modeling and therapeutic development.
Scientific recognition includes:
- Boehringer-Ingelheim-Fonds scholarships (1993-1996)
Prof. Schwenk has supervised numerous Bachelor's and Master's theses at prestigious institutions worldwide including Harvard Medical School, University of Edinburgh, and University of Cologne. He maintains a consulting role at Taconic Biosciences GmbH in Köln, advising on technology development and patents. His collaborative network spans multiple continents, reflecting the international significance of his research in genetic engineering and biomedical applications.
His laboratory focuses on developing and applying advanced genetic techniques using mouse models, with particular emphasis on conditional gene expression systems and stem cell differentiation pathways for modeling human diseases and developing therapeutic approaches.
